… or high-dose usage of glucocorticoids. This review article will discuss the application of
glucocorticoids in the treatment of patients with severe or critical COVID-19 and solid tumors of …

… may have an increased risk of severe COVID-19 and mortality. Therefore, physicians …
COVID-19 pandemic based on the drug (dose and duration), pre-existing comorbidities, COVID-19 …

… , dexamethasone treatment is a double-edged sword, as … arise in COVID-19 patients receiving
dexamethasone treatment. … At the beginning of the pandemic, the use of corticosteroids …

… to the forefront in the management of patients seeking … over the usage of corticosteroids in
COVID-19 patients. The … adrenal hyperplasia, hypercalcemia associated with cancer, and non-…

… Many potential beneficial effects of glucocorticoids in the treatment of COVID-19 have
been proposed. However, whether they are successful due to the general supportive benefits …

… Unfortunately, cancer treatments often lead to side effects … High doses of glucocorticoid
therapy initiated promptly when … adverse effect of anti-cancer treatment. It manifests as reduced …

… of glucocorticoids in different clinical scenarios of ICI-treated cancer patients presenting with
AI during this COVID-19 … However, GCs is a double-edged sword in the COVID-19 setting; …

… It is necessary to know the type of breast cancer to differentiate the treatment for estrogen …
DEX can act as a double-edged sword when it is used at different doses during breast cancer …

… role in the COVID-19 pandemic 7 . Because there are no … It is clear that using glucocorticoids
for the treatment of cancers … as a double-edged sword in breast cancer progression and …

… with SARSCoV-2, mostly presenting cancer, along with transplantation and immunodeficiency.
The … with or without COVID-19 who have strong indications for treatment like autoimmune …